Metabotropic glutamate receptor 2 inhibits thalamically-driven glutamate and dopamine release in the dorsal striatum

Por Johnson, Kari A., Mateo, Yolanda, Lovinger, David M.
Publicado no Neuropharmacology (2017)

Role of serotonin in cocaine effects in mice with reduced dopamine transporter function

Por Mateo, Yolanda, Budygin, Evgeny A., John, Carrie E., Jones, Sara R.
Publicado em 2004

Cocaine-insensitive dopamine transporters with intact substrate transport produced by self-administration

Por Ferris, Mark J., Mateo, Yolanda, Roberts, David C.S., Jones, Sara R.
Publicado em 2011

Dopamine dynamics and cocaine sensitivity differ between striosome and matrix compartments of the striatum

Por Salinas, Armando G., Davis, Margaret I., Lovinger, David M., Mateo, Yolanda
Publicado no Neuropharmacology (2016)

Endocannabinoid modulation of dopamine neurotransmission

Por Covey, Dan, Mateo, Yolanda, Sulzer, David, Cheer, Joseph F., Lovinger, David M.
Publicado no Neuropharmacology (2017)

Chronic methylphenidate exposure during adolescence reduces striatal synaptic responses to ethanol

Por Crowley, Nicole A., Cody, Patrick A., Davis, Margaret I., Lovinger, David M., Mateo, Yolanda
Publicado em 2013

Cocaine Self-Administration Produces Pharmacodynamic Tolerance: Differential Effects on the Potency of Dopamine Transporter Blockers, Releasers, and Methylphenidate

Por Ferris, Mark J, Calipari, Erin S, Mateo, Yolanda, Melchior, James R, Roberts, David CS, Jones, Sara R
Publicado em 2012

Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing

Por Cachope, Roger, Mateo, Yolanda, Mathur, Brian N., Irving, James, Wang, Hui-Ling, Morales, Marisela, Lovinger, David M., Cheer, Joseph F.
Publicado em 2012

Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine

Por Budygin, Evgeny A., Brodie, Mark S., Sotnikova, Tatyana D., Mateo, Yolanda, John, Carrie E., Cyr, Michel, Gainetdinov, Raul R., Jones, Sara R.
Publicado em 2004

Dopamine D2 Receptor Overexpression Alters Behavior and Physiology in Drd2-EGFP Mice

Por Kramer, Paul F., Christensen, Christine H., Hazelwood, Lisa A., Dobi, Alice, Bock, Roland, Sibley, David R., Mateo, Yolanda, Alvarez, Veronica A.
Publicado em 2011

Chronic ethanol self-administration in macaques shifts dopamine feedback inhibition to predominantly D2 receptors in nucleus accumbens core

Por Siciliano, Cody A., Calipari, Erin S., Yorgason, Jordan T., Mateo, Yolanda, Helms, Christa M., Lovinger, David M., Grant, Kathleen A., Jones, Sara R.
Publicado no Drug Alcohol Depend (2015)

Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D(2) autoreceptors

Por Bello, Estefanía P, Mateo, Yolanda, Gelman, Diego M, Noaín, Daniela, Shin, Jung H, Low, Malcolm J, Alvarez, Verónica A, Lovinger, David M, Rubinstein, Marcelo
Publicado em 2011

Increased presynaptic regulation of dopamine neurotransmission in the nucleus accumbens core following chronic ethanol self-administration in female macaques

Por Siciliano, Cody A., Calipari, Erin S., Yorgason, Jordan T., Lovinger, David M., Mateo, Yolanda, Jimenez, Vanessa A., Helms, Christa M., Grant, Kathleen A., Jones, Sara R.
Publicado no Psychopharmacology (Berl) (2016)

Endocannabinoids on cortical terminals orchestrate local modulation of dopamine release in the nucleus accumbens

Por Mateo, Yolanda, Johnson, Kari A., Covey, Dan P., Atwood, Brady K., Wang, Hui-Ling, Zhang, Shiliang, Gildish, Iness, Cachope, Roger, Bellocchio, Luigi, Guzmán, Manuel, Morales, Marisela, Cheer, Joseph F., Lovinger, David M.
Publicado no Neuron (2017)

Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic...

Por Liu, Guoxiang, Sgobio, Carmelo, Gu, Xinglong, Sun, Lixin, Lin, Xian, Yu, Jia, Parisiadou, Loukia, Xie, Chengsong, Sastry, Namratha, Ding, Jinhui, Lohr, Kelly M., Miller, Gary W., Mateo, Yolanda, Lovinger, David M., Cai, Huaibin
Publicado no Hum Mol Genet (2015)

Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging

Por Jaaro-Peled, Hanna, Niwa, Minae, Foss, Catherine A., Murai, Rina, de los Reyes, Samantha, Kamiya, Atsushi, Mateo, Yolanda, O'Donnell, Patricio, Cascella, Nicola G., Nabeshima, Toshitaka, Guilarte, Tomás R., Pomper, Martin G., Sawa, Akira
Publicado em 2013

Conditional Expression of Parkinson's Disease-Related Mutant α-Synuclein in the Midbrain Dopaminergic Neurons Causes Progressive Neurodegeneration and Degradation of Transcription...

Por Lin, Xian, Parisiadou, Loukia, Sgobio, Carmelo, Liu, Guoxiang, Yu, Jia, Sun, Lixin, Shim, Hoon, Gu, Xing-Long, Luo, Jing, Long, Cai-Xia, Ding, Jinhui, Mateo, Yolanda, Sullivan, Patricia H., Wu, Ling-Gang, Goldstein, David S., Lovinger, David, Cai, Huaibin
Publicado em 2012

Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus

Por Kolata, Stefan M, Nakao, Kazuhito, Jeevakumar, Vivek, Farmer-Alroth, Emily L, Fujita, Yuko, Bartley, Aundrea F, Jiang, Sunny Zhihong, Rompala, Gregory R, Sorge, Robert E, Jimenez, Dennisse V, Martinowich, Keri, Mateo, Yolanda, Hashimoto, Kenji, Dobrunz, Lynn E, Nakazawa, Kazu
Publicado no Neuropsychopharmacology (2018)